NO20064358L - Svovelforbindelser som inhibitorer for hepatitt C-virum-NS3-serinprotease - Google Patents
Svovelforbindelser som inhibitorer for hepatitt C-virum-NS3-serinproteaseInfo
- Publication number
- NO20064358L NO20064358L NO20064358A NO20064358A NO20064358L NO 20064358 L NO20064358 L NO 20064358L NO 20064358 A NO20064358 A NO 20064358A NO 20064358 A NO20064358 A NO 20064358A NO 20064358 L NO20064358 L NO 20064358L
- Authority
- NO
- Norway
- Prior art keywords
- hepatitis
- inhibitors
- prior
- serine protease
- sulfur compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54867004P | 2004-02-27 | 2004-02-27 | |
PCT/US2005/005795 WO2005087731A1 (fr) | 2004-02-27 | 2005-02-24 | Composes soufres en tant qu'inhibiteurs de la protease serine ns3 du virus de l'hepatite c |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20064358L true NO20064358L (no) | 2006-11-24 |
Family
ID=34961556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064358A NO20064358L (no) | 2004-02-27 | 2006-09-26 | Svovelforbindelser som inhibitorer for hepatitt C-virum-NS3-serinprotease |
Country Status (31)
Country | Link |
---|---|
US (1) | US8067379B2 (fr) |
EP (1) | EP1730110B9 (fr) |
JP (1) | JP4714732B2 (fr) |
KR (2) | KR101316137B1 (fr) |
CN (2) | CN103102389A (fr) |
AR (1) | AR048241A1 (fr) |
AT (1) | ATE470660T1 (fr) |
AU (1) | AU2005222060A1 (fr) |
BR (1) | BRPI0508085A (fr) |
CA (1) | CA2557495C (fr) |
CY (1) | CY1111212T1 (fr) |
DE (1) | DE602005021760D1 (fr) |
DK (1) | DK1730110T3 (fr) |
EC (1) | ECSP066791A (fr) |
ES (1) | ES2346233T3 (fr) |
HK (1) | HK1095819A1 (fr) |
HR (1) | HRP20100416T1 (fr) |
IL (1) | IL177544A (fr) |
MY (1) | MY145081A (fr) |
NO (1) | NO20064358L (fr) |
NZ (1) | NZ549223A (fr) |
PE (1) | PE20051150A1 (fr) |
PL (1) | PL1730110T3 (fr) |
PT (1) | PT1730110E (fr) |
RS (1) | RS51394B (fr) |
RU (1) | RU2428428C9 (fr) |
SG (1) | SG186041A1 (fr) |
SI (1) | SI1730110T1 (fr) |
TW (2) | TWI393704B (fr) |
WO (1) | WO2005087731A1 (fr) |
ZA (1) | ZA200607096B (fr) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU227742B1 (en) | 1996-10-18 | 2012-02-28 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
US7816326B2 (en) * | 2004-02-27 | 2010-10-19 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
PT1730110E (pt) * | 2004-02-27 | 2010-09-14 | Schering Corp | Compostos de enxofre como inibidores de serina-protease ns3 do vírus da hepatite c |
GB0426661D0 (en) * | 2004-12-06 | 2005-01-05 | Isis Innovation | Pyrrolidine compounds |
WO2006130666A2 (fr) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Medicaments et procedes destines a combiner un inhibiteur de protease hcv et un competiteur akr |
WO2006130686A2 (fr) | 2005-06-02 | 2006-12-07 | Schering Corporation | Administration d'inhibiteurs de protease du vhc en combinaison avec des aliments pour ameliorer la biodisponibilite |
BRPI0610737A2 (pt) * | 2005-06-02 | 2010-07-20 | Schering Corp | formulações farmacêuticas e métodos de tratamento usando as mesmas |
US20060276407A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Methods of treating hepatitis C virus |
US20070237818A1 (en) * | 2005-06-02 | 2007-10-11 | Malcolm Bruce A | Controlled-release formulation of HCV protease inhibitor and methods using the same |
CA2611145A1 (fr) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Formulation a liberation controlee |
US20060275366A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation |
WO2006130626A2 (fr) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Procede de modulation de l'activite de la protease du vhc au moyen d'un nouvel inhibiteur de la protease du vhc aux fins de la reduction de la duree du traitement |
WO2006130687A2 (fr) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Taux de concentration foie/plasma pour le dosage de l'inhibiteur de protease du virus de l'hepatite c |
WO2006130552A2 (fr) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Methodes de traitement du virus de l'hepatite c |
AR055395A1 (es) | 2005-08-26 | 2007-08-22 | Vertex Pharma | Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c |
US7816348B2 (en) | 2006-02-03 | 2010-10-19 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
CA2644389A1 (fr) * | 2006-03-03 | 2007-09-20 | Schering Corporation | Associations comprenant un ou des inhibiteur(s) de la protease de l'hcv et un ou des inhibiteur(s)de l'ires de l'hcv, et procedes therapeutiques apparentes |
AU2007227580A1 (en) | 2006-03-16 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Processes and intermediates for preparing steric compounds |
WO2007111866A2 (fr) * | 2006-03-23 | 2007-10-04 | Schering Corporation | Combinaisons d'un ou plusieurs inhibiteurs de la protéase du vhc et d'un ou plusieurs inhibiteurs de cyp3a4, et méthodes de traitement associées |
RU2448976C2 (ru) | 2006-04-11 | 2012-04-27 | Новартис Аг | Ингибиторы hcv/вич и их применение |
DE102006059317A1 (de) | 2006-07-04 | 2008-01-10 | Evonik Degussa Gmbh | Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden |
CN101506167A (zh) | 2006-08-17 | 2009-08-12 | 贝林格尔.英格海姆国际有限公司 | 病毒聚合酶抑制剂 |
US20100081672A1 (en) * | 2006-12-07 | 2010-04-01 | Schering Corporation | Ph sensitive matrix formulation |
AU2007339382B2 (en) | 2006-12-22 | 2013-05-02 | Merck Sharp & Dohme Llc | 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections |
WO2008078563A1 (fr) * | 2006-12-22 | 2008-07-03 | Sumitomo Seika Chemicals Co., Ltd. | Procédé de fabrication du 3-benzyloxybenzènethiol |
JP5211068B2 (ja) | 2006-12-22 | 2013-06-12 | メルク・シャープ・アンド・ドーム・コーポレーション | Hcvおよび関連するウイルス疾患の治療または予防のための4,5−環インドール誘導体 |
JP5055377B2 (ja) | 2006-12-22 | 2012-10-24 | シェーリング コーポレイション | [5,6−環]環形成インドール誘導体およびその使用方法 |
CA2693997C (fr) | 2007-08-03 | 2013-01-15 | Pierre L. Beaulieu | Inhibiteurs de polymerase virale |
WO2009032124A1 (fr) | 2007-08-29 | 2009-03-12 | Schering Corporation | Dérivés d'indole substitués et procédés d'utilisation associés |
US8143305B2 (en) | 2007-08-29 | 2012-03-27 | Schering Corporation | 2,3-substituted indole derivatives for treating viral infections |
CN101842374A (zh) | 2007-08-29 | 2010-09-22 | 先灵公司 | 用于治疗病毒感染的2,3-取代的氮杂吲哚衍生物 |
JP2010539165A (ja) | 2007-09-14 | 2010-12-16 | シェーリング コーポレイション | C型肝炎患者を処置する方法 |
AR068756A1 (es) | 2007-10-10 | 2009-12-02 | Novartis Ag | Compuestos peptidicos, formulacion farmaceutica y sus usos como moduladores del virus de la hepatitis c |
WO2009064848A1 (fr) | 2007-11-16 | 2009-05-22 | Schering Corporation | Dérivés d'indole à substitution hétérocyclique en position 3 et leurs procédés d'utilisation |
JP5416708B2 (ja) | 2007-11-16 | 2014-02-12 | メルク・シャープ・アンド・ドーム・コーポレーション | 3−アミノスルホニル置換インドール誘導体およびそれらの使用方法 |
WO2009076747A1 (fr) | 2007-12-19 | 2009-06-25 | Boehringer Ingelheim International Gmbh | Inhibiteurs de polymérase virale |
US7964560B2 (en) * | 2008-05-29 | 2011-06-21 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
CA2727620A1 (fr) | 2008-06-13 | 2009-12-17 | Schering Corporation | Derives d'indole tricycliques et procedes d'utilisation de ceux-ci |
US20110207660A1 (en) * | 2008-08-07 | 2011-08-25 | Schering Corporation | Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion |
US8188137B2 (en) | 2008-08-15 | 2012-05-29 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
AR074582A1 (es) | 2008-12-12 | 2011-01-26 | Schering Corp | Compuestos deuterados como inhibidores del virus de la hepatitis c (hcv) |
RU2011127080A (ru) | 2009-01-07 | 2013-02-20 | Сайнексис, Инк. | Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич |
US8512690B2 (en) | 2009-04-10 | 2013-08-20 | Novartis Ag | Derivatised proline containing peptide compounds as protease inhibitors |
AU2010253791A1 (en) | 2009-05-29 | 2011-11-24 | Merck Sharp & Dohme Corp. | Antiviral compounds composed of three linked Aryl moieties to treat diseases such as Hepatitis C |
IN2012DN00346A (fr) | 2009-07-29 | 2015-05-08 | Schering Corp | |
AU2010324871A1 (en) | 2009-11-25 | 2012-06-14 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases |
US20130156731A1 (en) | 2009-12-22 | 2013-06-20 | Kevin X. Chen | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
SG183526A1 (en) | 2010-03-09 | 2012-09-27 | Merck Sharp & Dohme | Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
US20140377223A1 (en) | 2010-07-26 | 2014-12-25 | Joseph A. Kozlowski | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
US9133116B2 (en) | 2010-09-28 | 2015-09-15 | Panacea Biotec Ltd. | Bicyclic compounds |
US9254292B2 (en) | 2010-09-29 | 2016-02-09 | Merck Sharp & Dohme Corp. | Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases |
WO2012073249A1 (fr) | 2010-12-01 | 2012-06-07 | Arch Pharmalabs Limited | Nouveau procédé de préparation de 3-(benzyloxy)-benzènethiol, un intermédiaire clé pour la préparation de médicaments pharmaceutiques |
EA201391519A1 (ru) | 2011-04-13 | 2014-03-31 | Мерк Шарп И Доум Корп. | 2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний |
EP2697242B1 (fr) | 2011-04-13 | 2018-10-03 | Merck Sharp & Dohme Corp. | Dérivés de nucléosides à substitution 2'-azido et leurs procédés d'utilisation pour le traitement de maladies virales |
WO2013033901A1 (fr) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Dérivés benzofuranes substitués par un hétérocycle et leurs procédés d'utilisation pour le traitement de maladies virales |
WO2013033899A1 (fr) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Composés benzofuranes substitués et leur procédés d'utilisation pour le traitement de maladies virales |
WO2013033900A1 (fr) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de maladies virales |
WO2013039876A1 (fr) | 2011-09-14 | 2013-03-21 | Merck Sharp & Dohme Corp. | Composés hétérocycliques contenant un silyle et méthodes d'utilisation desdits composés pour traiter les maladies virales |
EP3063140A4 (fr) | 2013-10-30 | 2017-11-08 | Merck Sharp & Dohme Corp. | Pseudopolymorphes d'un inhibiteur de la protéine ns5a du vhc et leurs utilisations |
WO2017059446A1 (fr) * | 2015-10-01 | 2017-04-06 | Memorial Sloan-Kettering Cancer Center | Analogues de l'anthranilyl-adénosinemonosulfamate et leurs utilisations |
EP3356447A4 (fr) * | 2015-10-01 | 2019-06-12 | Memorial Sloan-Kettering Cancer Center | Inhibiteurs de la biosynthèse de la ménaquinone |
MX2018016102A (es) * | 2016-06-21 | 2019-08-29 | Orion Ophthalmology LLC | Derivados alifaticos de prolinamida. |
US20230218644A1 (en) | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL169273B1 (pl) | 1990-04-04 | 1996-06-28 | Chiron Corp | skierowanej przeciw wirusowi zapalenia watroby C PL |
US5922757A (en) | 1996-09-30 | 1999-07-13 | The Regents Of The University Of California | Treatment and prevention of hepatic disorders |
HU227742B1 (en) | 1996-10-18 | 2012-02-28 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
JP4452401B2 (ja) | 1997-08-11 | 2010-04-21 | ベーリンガー インゲルハイム (カナダ) リミテッド | C型肝炎ウイルス阻害ペプチドアナログ |
US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
AR022061A1 (es) | 1998-08-10 | 2002-09-04 | Boehringer Ingelheim Ca Ltd | Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos. |
US6608027B1 (en) | 1999-04-06 | 2003-08-19 | Boehringer Ingelheim (Canada) Ltd | Macrocyclic peptides active against the hepatitis C virus |
AU2001251165A1 (en) | 2000-04-03 | 2001-10-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
ES2317900T3 (es) | 2000-04-05 | 2009-05-01 | Schering Corporation | Inhibidores de serina proteasa ns3 macrociclicos del virus de la hepatitis c que comprenden fragmentos n-ciclicas p2. |
CN1432022A (zh) | 2000-04-19 | 2003-07-23 | 先灵公司 | 含有烷基和芳基丙氨酸p2部分的丙型肝炎病毒的大环ns3-丝氨酸蛋白酶抑制剂 |
WO2002008251A2 (fr) | 2000-07-21 | 2002-01-31 | Corvas International, Inc. | Nouveaux peptides utilises comme inhibiteurs de ns3-serine protease du virus de l'hepatite c |
HUP0303358A3 (en) | 2000-07-21 | 2005-10-28 | Schering Corp | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus and pharmaceutical compositions containing them |
KR100904788B1 (ko) * | 2000-07-21 | 2009-06-25 | 쉐링 코포레이션 | C형 간염 바이러스의 ns3-세린 프로테아제억제제로서의 신규한 펩티드 |
US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
AR029851A1 (es) | 2000-07-21 | 2003-07-16 | Dendreon Corp | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c |
SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
KR20030091946A (ko) | 2000-12-12 | 2003-12-03 | 쉐링 코포레이션 | C형 간염 바이러스의 ns3-세린 프로테아제억제제로서의 디아릴 펩티드 |
US7816326B2 (en) | 2004-02-27 | 2010-10-19 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
PT1730110E (pt) | 2004-02-27 | 2010-09-14 | Schering Corp | Compostos de enxofre como inibidores de serina-protease ns3 do vírus da hepatite c |
BRPI0610737A2 (pt) | 2005-06-02 | 2010-07-20 | Schering Corp | formulações farmacêuticas e métodos de tratamento usando as mesmas |
-
2005
- 2005-02-24 PT PT05723607T patent/PT1730110E/pt unknown
- 2005-02-24 RS RSP-2010/0360A patent/RS51394B/en unknown
- 2005-02-24 KR KR1020067017257A patent/KR101316137B1/ko not_active IP Right Cessation
- 2005-02-24 PL PL05723607T patent/PL1730110T3/pl unknown
- 2005-02-24 US US11/064,673 patent/US8067379B2/en active Active
- 2005-02-24 MY MYPI20050737A patent/MY145081A/en unknown
- 2005-02-24 AR ARP050100679A patent/AR048241A1/es not_active Application Discontinuation
- 2005-02-24 AT AT05723607T patent/ATE470660T1/de active
- 2005-02-24 AU AU2005222060A patent/AU2005222060A1/en not_active Abandoned
- 2005-02-24 BR BRPI0508085-1A patent/BRPI0508085A/pt not_active IP Right Cessation
- 2005-02-24 DK DK05723607.7T patent/DK1730110T3/da active
- 2005-02-24 WO PCT/US2005/005795 patent/WO2005087731A1/fr active Application Filing
- 2005-02-24 NZ NZ549223A patent/NZ549223A/en not_active IP Right Cessation
- 2005-02-24 CA CA2557495A patent/CA2557495C/fr not_active Expired - Fee Related
- 2005-02-24 TW TW098107879A patent/TWI393704B/zh not_active IP Right Cessation
- 2005-02-24 CN CN2012103533032A patent/CN103102389A/zh active Pending
- 2005-02-24 SI SI200531086T patent/SI1730110T1/sl unknown
- 2005-02-24 ES ES05723607T patent/ES2346233T3/es active Active
- 2005-02-24 EP EP05723607A patent/EP1730110B9/fr active Active
- 2005-02-24 RU RU2006134003/04A patent/RU2428428C9/ru active
- 2005-02-24 CN CNA2005800128593A patent/CN101076516A/zh active Pending
- 2005-02-24 JP JP2007500955A patent/JP4714732B2/ja not_active Expired - Fee Related
- 2005-02-24 TW TW094105518A patent/TWI314927B/zh not_active IP Right Cessation
- 2005-02-24 KR KR1020127034290A patent/KR20130018418A/ko not_active Application Discontinuation
- 2005-02-24 PE PE2005000220A patent/PE20051150A1/es not_active Application Discontinuation
- 2005-02-24 DE DE602005021760T patent/DE602005021760D1/de active Active
- 2005-02-24 SG SG2012087664A patent/SG186041A1/en unknown
-
2006
- 2006-08-17 IL IL177544A patent/IL177544A/en not_active IP Right Cessation
- 2006-08-24 ZA ZA200607096A patent/ZA200607096B/xx unknown
- 2006-08-25 EC EC2006006791A patent/ECSP066791A/es unknown
- 2006-09-26 NO NO20064358A patent/NO20064358L/no not_active Application Discontinuation
-
2007
- 2007-03-19 HK HK07102951.6A patent/HK1095819A1/xx not_active IP Right Cessation
-
2010
- 2010-07-27 HR HR20100416T patent/HRP20100416T1/hr unknown
- 2010-09-01 CY CY20101100796T patent/CY1111212T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064358L (no) | Svovelforbindelser som inhibitorer for hepatitt C-virum-NS3-serinprotease | |
NO20064357L (no) | Nye forbindelser som inhibitorer for hepatitt C-virus-NS3-serinprotease | |
NO20064356L (no) | Forbindelser som inhibitorer for hepatitt C-virun-NS3-erinprotease | |
NO20063205L (no) | Inhibitorer for hepatitt C-virus NS3/NS4A-serinprotease | |
NO20064355L (no) | Nye ketoamider med sykliske P4-er som inhibitorer for NS3-serinprotease fra hepatitt C-virus | |
ATE513844T1 (de) | Acylsulfonamidverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus | |
NO20030271L (no) | Nye peptider som NS3-serinproteaseinhibitorer for hepatitt C- virus | |
TWI265927B (en) | Novel compounds as NS3-serine protease inhibitors of hepatitis C virus | |
MX2009011064A (es) | Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c. | |
NO20081467L (no) | Inhibitorer av sennproteaser | |
MY140710A (en) | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus | |
WO2008118332A3 (fr) | Peptides hydrazido en tant qu'inhibiteurs de la protéase ns3 du hcv | |
WO2005051980A8 (fr) | Inhibiteurs depourvus de liaisons peptidiques de la protease ns3 du virus de l'hepatite c | |
NO20082476L (no) | Bicykliske forbindelser med kinaseinhiberende aktivitet | |
NO20061822L (no) | Makrosykliske inhibitorer av hepatitt C-virus-NS3-serinprotease | |
WO2009008913A3 (fr) | Inhibiteurs de cétoamides de p1 non épimérisables de protéase de ns3 du virus de l'hépatite c (vhc) | |
MX2010004704A (es) | Inhibidores macrociclicos de la ns3 serina proteasa del virus de la hepatitis c. | |
MXPA03000627A (es) | Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c. | |
NO20084652L (no) | Deazapuriner anvendelige som inhibitorer av januskinaser | |
EA200970349A1 (ru) | Ингибиторы металлопротеазы гетероциклического происхождения | |
WO2010021717A3 (fr) | Inhibiteurs de la protéase du vhc | |
NO20075370L (no) | Alfa-ketoamidforbindelser som cysteinproteaseinhibitorer | |
WO2010068714A3 (fr) | Composés deutérés en tant qu'inhibiteurs du virus de l'hépatite c (vhc) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: MERCK SHARP AND DOHME CORP, US Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |